Company profile: Cristcot
1.1 - Company Overview
Company description
- Provider of drug delivery systems that combine products and specialty drug formulations, including Novel Rescue for UC Flares, a drug in Phase 3 clinical trials designed to achieve clinical remission in ulcerative colitis via mucosal healing within 4 weeks, and a patented hydrocortisone acetate suppository delivered with the Sephure applicator for consistent drug delivery and rapid bioavailability.
Products and services
- Drug Delivery Systems Development: Architects systems combining products with specialty drug formulations into integrated pairs
- Custom-engineered
- Novel Rescue for UC Flares: A Phase 3 drug engineered to achieve clinical remission in ulcerative colitis via mucosal healing within 4 weeks
- Patented Suppository for the Treatment of UC: A hydrocortisone acetate suppository delivered with the Sephure applicator for consistent delivery and rapid bioavailability in ulcerative colitis.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Cristcot
EnginZyme
HQ: Sweden
Website
- Description: Provider of a patented cell-free biomanufacturing platform and services for the sustainable production of common goods. Offers EziG immobilized enzyme cascades enabling continuous, organism-free operation; automated biocatalyst design; integrated bioprocess engineering and scale-up from catalyst design to commercialization; and a patented enzymatic pseudouridine synthesis for mRNA vaccines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full EnginZyme company profile →
Bioanalytical Systems
HQ: United States
Website
- Description: Provider of contract development services and specialized equipment for pharmaceutical, medical research, and biotechnology organizations, including electrochemistry and low-stress in vivo sampling products (electrodes, cell packages, accessories), electrochemical analyzers (potentiostats, galvanostats, EIS), animal catheters and extenders, educational electrochemistry kits, and the Raturn movement-responsive caging system for tether-based applications.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Bioanalytical Systems company profile →
Peloton Therapeutics
HQ: United States
Website
- Description: Provider of cancer drug discovery and development based in Dallas. Offers a clinical-stage small-molecule HIF-2α inhibitor targeting hypoxia-inducible factor-2α for kidney cancer and other disorders, and research programs to discover compounds that modulate disease-driving protein-protein interactions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Peloton Therapeutics company profile →
Ethypharm
HQ: France
Website
- Description: Provider of pharmaceutical products for the treatment of pains and addictions, designing, formulating, developing, manufacturing, and marketing them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethypharm company profile →
SEPS Pharma
HQ: Belgium
Website
- Description: Provider of drug product development services, encompassing preformulation and formulation development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SEPS Pharma company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Cristcot
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Cristcot
2.2 - Growth funds investing in similar companies to Cristcot
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Cristcot
4.2 - Public trading comparable groups for Cristcot
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →